HDAC8 and neuroblastoma: HDAC8-targeting combined treatment was also investigated in neuroblastoma models: BE(2)-C neuroblastoma xenografts were simultaneously treated with PCI-48012 (the structure of which is still undisclosed), a more stable analogue of PCI-34051 (1), and retinoic acid.